Posts in category All News
IPO Review – Discussion until listing (11-11-2024)
Onyx Biotec Limited is a pharmaceutical company providing sterile water for injections.
Getting to Know Onyx Biotec Ltd. | Exclusive interview with Mr Harsh and Mr Lakshya | SMEmitra
Why FSSAI called up qcom companies (11-11-2024)
The Food Safety and Standards Authority of India (FSSAI) has sought a meeting with quick-commerce (qcom) platforms like Blinkit, Swiggy Instamart and Zepto on Tuesday to discuss issues regarding violations of food safety standards, according to sources familiar with the matter. This comes at a time when there have been issues raised about food safety standard violations by qcom platforms for packaged food products, including violations related to expiry and best before dates.
US dollar index net speculative long positions fall slightly (11-11-2024)
US dollar index speculators reduced their net long position, according to the latest Commitment of Traders (COT) data released by the Commodity Futures Trading Commission (CFTC). The non-commercial futures contracts of US dollar index futures, traded by large speculators and hedge funds, totaled a net long position of 95 contracts in the data reported through November 05, 2024, showing a decrease of 1589 net long contracts compared to the previous week.
Holmarc Opto-Mechatronics – R&D play (11-11-2024)
An incorrect assumption that we might be making is that only retail reads Valuepickr.
Equitas SFB hits 52-week low after Q2 PAT slumps 94% YoY (11-11-2024)
Equitas Small Finance Bank (Equitas SFB) slipped 6.10% to Rs 64.50 after the bank reported net profit tumbled 93.5% to Rs 12.88 crore in Q2 FY25 as against Rs 198.14 crore recorded in Q2 FY24.
PFC shares jump 7% post Q2 results; Brokerages maintain bullish outlook (11-11-2024)
PFC Share Price: Power Finance Corporation shares rose 9% after reporting a 9% increase in Q2 profit, driven by higher revenues and loan growth. Brokerages Bernstein and CLSA maintain ‘Outperform’ ratings.
Vivek Gautam Portfolio (11-11-2024)
AKUMS just posted the Q2 results, wherein the YoY revenue dipped a bit, whereas new profit doubled. However, the market has not cheered this news with the stock being down 4% today and about 40% down from its peak post-IPO in August.
If anyone attended their con-call, can you pls share your notes?
Looking to understand the growth story from here, and short term triggers if any
thanks
Naukri.com parent Info Edge climbs 5% in trade; What’s boosting the rally? (11-11-2024)
Info Edge declared an interim dividend of Rs 12 per share and fixed the record date as Wednesday, November 20, 2024